Table 2.
Group | P | ||
---|---|---|---|
Controls (n=99), n (%) | Cases (n=21), n (%) | ||
Diagnosis | |||
Valvular heart disease | 44 (44.4) | 9 (42.9) | 0.894 |
Coronary artery disease | 36 (36.4) | 11 (52.4) | 0.172 |
Acyanotic congenital heart disease | 10 (10.1) | 1 (4.8) | 0.723** |
Congenital cyanotic heart disease | 2 (2.0) | 0 | 0.778** |
Vascular surgery | 7 (7.1) | 0 | 0.457** |
Drug abuse | 2 (2.0) | 1 (4.8) | 1.000** |
Alcoholic | 12 (12.1) | 4 (19.0) | 0.621** |
HTN | 27 (27.3) | 15 (71.4) | <0.0001 |
Diabetes | 15 (15.2) | 8 (38.1) | 0.034** |
Thyroid disease | 4 (4) | 0 | 0.789** |
History of cardiac surgery | 9 (9.1) | 2 (9.5) | 1.000** |
History of stroke | 5 (5.1) | 2 (9.5) | 0.778** |
Vascular disease | 4 (4.0) | 1 (4.8) | 1.000** |
Depression | 1 (1.0) | 0 | 1.000** |
Renal dysfunction | 3 (3.0) | 4 (19.0) | 0.020** |
LVEF<30% | 8 (8.1) | 0 | 0.386** |
Atrial fibrillation | 17 (17.2) | 1 (4.8) | 0.267** |
Emergency surgery | 7 (7.1) | 1 (4.8) | 1.000** |
Cardiogenic shock | 2 (2) | 0 | 1.000** |
Severe PAH% | 8 (8.1) | 1 (4.8) | 0.945** |
NYHA 3 or 4 | 36 (36.4) | 14 (66.7) | 0.011 |
Premedication | 88 (88.9) | 18 (85.7) | 0.970** |
Carotid artery disease | 5 (5.1) | 7 (33.3) | <0.0001 |
**Yate’s corrected Chi-square test. LVEF: Left ventricular ejection fraction, PAH: Pulmonary artery hypertension, NYHA: New York Heart Association, HTN: Hypertension